Tirzepatide

Revision as of 17:42, 18 August 2022 by Kfarzam (talk | contribs) (Created page with "Tirzepatide is a dual GIP and GLP-1 agonist approved for the treatment of type 2 diabetes and also used off-label for obesity treatment")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tirzepatide is a dual GIP and GLP-1 agonist approved for the treatment of type 2 diabetes and also used off-label for obesity treatment